Thissen MR - Search Results

1

A systematic review of treatment modalities for primary basal cell carcinomas.

Thissen MR, Neumann MH, Schouten LJ. Thissen MR, et al. Arch Dermatol. 1999 Oct;135(10):1177-83. doi: 10.1001/archderm.135.10.1177. Arch Dermatol. 1999. PMID: 10522664 Review.

2

Laser treatment for further depigmentation in vitiligo.

Thissen M, Westerhof W. Thissen M, et al. Int J Dermatol. 1997 May;36(5):386-8. doi: 10.1046/j.1365-4362.1997.00144.x. Int J Dermatol. 1997. PMID: 9199992 Clinical Trial.

3

[The treatment of basal cell carcinoma patients by dermatologists in Netherland].

Thissen MR, Neumann HA, Berretty PJ, Ideler AH. Thissen MR, et al. Ned Tijdschr Geneeskd. 1998 Jul 4;142(27):1563-7. Ned Tijdschr Geneeskd. 1998. PMID: 9763832 Dutch.

4

Photodynamic therapy with delta-aminolaevulinic acid for nodular basal cell carcinomas using a prior debulking technique.

Thissen MR, Schroeter CA, Neumann HA. Thissen MR, et al. Br J Dermatol. 2000 Feb;142(2):338-9. doi: 10.1046/j.1365-2133.2000.03404.x. Br J Dermatol. 2000. PMID: 10730770 Clinical Trial.

5

Cosmetic results of cryosurgery versus surgical excision for primary uncomplicated basal cell carcinomas of the head and neck.

Thissen MR, Nieman FH, Ideler AH, Berretty PJ, Neumann HA. Thissen MR, et al. Dermatol Surg. 2000 Aug;26(8):759-64. doi: 10.1046/j.1524-4725.2000.ds00064.x. Dermatol Surg. 2000. PMID: 10940063 Clinical Trial.

6

PpIX fluorescence kinetics and increased skin damage after intracutaneous injection of 5-aminolevulinic acid and repeated illumination.

Thissen MR, de Blois MW, Robinson DJ, de Bruijn HS, Dutrieux RP, Star WM, Neumann HA. Thissen MR, et al. J Invest Dermatol. 2002 Feb;118(2):239-45. doi: 10.1046/j.0022-202x.2001.01571.x. J Invest Dermatol. 2002. PMID: 11841539

7

[Low 5-year remission percentage after surgical treatment of 126 basal cell carcinomas with frozen section diagnosis].

Krekels GA, Thissen MR. Krekels GA, et al. Among authors: thissen mr. Ned Tijdschr Geneeskd. 2002 Feb 2;146(5):237-8. Ned Tijdschr Geneeskd. 2002. PMID: 11851088 Dutch. No abstract available.

8

Basal cell carcinoma: treatment options and prognosis, a scientific approach to a common malignancy.

Kuijpers DI, Thissen MR, Neumann MH. Kuijpers DI, et al. Among authors: thissen mr. Am J Clin Dermatol. 2002;3(4):247-59. doi: 10.2165/00128071-200203040-00003. Am J Clin Dermatol. 2002. PMID: 12010070 Review.

9

Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion.

Sterry W, Ruzicka T, Herrera E, Takwale A, Bichel J, Andres K, Ding L, Thissen MR. Sterry W, et al. Among authors: thissen mr. Br J Dermatol. 2002 Dec;147(6):1227-36. doi: 10.1046/j.1365-2133.2002.05069.x. Br J Dermatol. 2002. PMID: 12452875 Clinical Trial.

10

The garlic-derived organosulfur component ajoene decreases basal cell carcinoma tumor size by inducing apoptosis.

Tilli CM, Stavast-Kooy AJ, Vuerstaek JD, Thissen MR, Krekels GA, Ramaekers FC, Neumann HA. Tilli CM, et al. Among authors: thissen mr. Arch Dermatol Res. 2003 Jul;295(3):117-23. doi: 10.1007/s00403-003-0404-9. Epub 2003 May 20. Arch Dermatol Res. 2003. PMID: 12756587

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results